VGM & ASSOCIATESHealthcare MSO
Full Menu Search

Proposed Decision Memo For Non-Invasive Ventilators

Published in Government Relations on March 14, 2025

The Centers for Medicare & Medicaid Services (CMS) released a decision memo on Tuesday, March 11, for a proposal NCD for noninvasive ventilation (NIV) for the treatment of chronic respiratory failure secondary to chronic obstructive pulmonary disease (COPD).

VGM is working with the industry to review the details and provide comments due on April 10.

At an initial review, here are a few highlights from the proposal:

  • In the proposal related to the RAD policy for COPD diagnosis, the requirement of qualifying with a sleep oximetry has been removed. This has been the most challenging to meet in the past. The proposal has removed it from the policy.
  • The initial coverage criteria have specific qualifications listed for a RAD that are in bold below.

Initial Coverage Criteria - RAD with Backup Rate Feature

CMS proposes to cover a RAD with backup rate feature in the home to deliver high intensity NIV as treatment for an individual with chronic respiratory failure (CRF) consequent to COPD. A RAD with backup rate feature must be utilized in the high intensity mode (IPAP > 20 cm H2O and backup respiratory rate of at least 14 breaths per minute). A RAD with backup rate feature is covered in the home for an initial 180-day period for individuals with COPD when all the following criteria are met:

  • The individual exhibits persistent hypercapnia as demonstrated by PaCO2 ≥ 52 mmHg by arterial blood gas during awake hours while breathing his/her prescribed FiO2;
  • Sleep apnea is not the predominant cause of the hypercapnia;
  • The individual exhibits the physical and cognitive ability to support home ventilation or has a caregiver who can assist, and;

The individual demonstrates one of the following characteristics:

  • Stable COPD, defined as no increase in or new onset of more than one respiratory symptom (cough, sputum production, sputum purulence, wheezing, or dyspnea) lasting 2 or more days and no change of pharmacological treatment during the 4-week period before initiation of NIV, or
  • Persistent hypercapnia for at least 2 weeks post hospitalization after resolution of an exacerbation of COPD requiring acute NIV.

There have been questions about adherence to the NIV and what the requirements consist of in the past this did not exist.

  • In the proposal the compliance to the NIV is using a minimum of 5 hours/24 period. In addition to a re-evaluation with the treating practitioner every 6 months before payment can be made.

Home Ventilation Continued Coverage

CMS proposes that individuals receiving coverage for an HMV as described in (i) and (ii) above must be re-evaluated by day 180 after receiving an HMV, and at least every 6 months thereafter, to establish that continued coverage by Medicare beyond the first 180-days is medical necessity. Medicare will not continue coverage into the 7th and succeeding months of therapy until the required re-evaluation is performed and establishes that continued coverage is medically necessary.

During a re-evaluation to establish that continued coverage is medically necessary, the practitioner must evaluate and verify that the HMV has been used for an average of at least 5 hours per 24-hour period in order to continue coverage of the device.

VGM will be commenting to the proposal that is due April 10. Once we have comments formulated and aligned with the industry, we will share with our members to assist with responding. To review the proposal in detail and to submit comments, please use this link.

Ronda Buhrmester

ronda.buhrmeter@vgm.com 

Boone Lockard

boone.lockard@vgm.com

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies. Gov't Shutdown & Telehealth Flexibility Expiration thumbnail Gov't Shutdown & Telehealth Flexibility Expiration September 30 represents an important date for HME providers for two reasons: 1) The potential of a government shutdown and how that affects HHS and CMS, and 2) the expiration of Telehealth Flexibilities unless a Continuing Resolution (CR) is agreed upon in time.

Give your business an advantage over the competition.

Become a Member